Targeting nitric oxide for cancer therapy

D Hirst, T Robson - Journal of Pharmacy and Pharmacology, 2007 - Wiley Online Library
A blueprint for the ideal anticancer molecule would include most of the properties of nitric
oxide (NO•), but the ability to exploit these characteristics in a therapeutic setting requires a …

Targeting nitric oxide for cancer therapy

D Hirst, T Robson - Journal of Pharmacy and Pharmacology, 2007 - academic.oup.com
A blueprint for the ideal anticancer molecule would include most of the properties of nitric
oxide (NO•), but the ability to exploit these characteristics in a therapeutic setting requires a …

[PDF][PDF] Targeting nitric oxide for cancer therapy

D Hirst, T Robson - JPP, 2007 - researchgate.net
A blueprint for the ideal anticancer molecule would include most of the properties of nitric
oxide (NO•), but the ability to exploit these characteristics in a therapeutic setting requires a …

[PDF][PDF] Targeting nitric oxide for cancer therapy

D Hirst, T Robson - JPP, 2007 - academia.edu
A blueprint for the ideal anticancer molecule would include most of the properties of nitric
oxide (NO•), but the ability to exploit these characteristics in a therapeutic setting requires a …

Targeting nitric oxide for cancer therapy.

D Hirst, T Robson - The Journal of Pharmacy and Pharmacology, 2007 - europepmc.org
A blueprint for the ideal anticancer molecule would include most of the properties of nitric
oxide (NO*), but the ability to exploit these characteristics in a therapeutic setting requires a …

[引用][C] Targeting nitric oxide for cancer therapy.

D Hirst, T Robson - Journal of Pharmacy and Pharmacology, 2007 - pure.qub.ac.uk
Targeting nitric oxide for cancer therapy. — Queen's University Belfast Skip to main navigation
Skip to search Skip to main content Queen's University Belfast Home Queen's University Belfast …

Targeting nitric oxide for cancer therapy

D Hirst, T Robson - The Journal of pharmacy and …, 2007 - pubmed.ncbi.nlm.nih.gov
A blueprint for the ideal anticancer molecule would include most of the properties of nitric
oxide (NO*), but the ability to exploit these characteristics in a therapeutic setting requires a …